Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Most Cited & Viewed
Most Cited & Viewed Papers
Citations | Article |
---|---|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
by
Hamid Mithoowani and Michela Febbraro
|
|
Immunotherapy in Gastric Cancer
by
Anica Högner and Markus Moehler
|
|
Pathological Features and Prognostication in Colorectal Cancer
by
Kabytto Chen, Geoffrey Collins, Henry Wang and James Wei Tatt Toh
|
|
Current Overview of Treatment for Metastatic Bone Disease
by
Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
|
|
Classification of Brain Tumor from Magnetic Resonance Imaging Using Vision Transformers Ensembling
by
Sudhakar Tummala, Seifedine Kadry, Syed Ahmad Chan Bukhari and Hafiz Tayyab Rauf
|
|
Detection of Cervical Cancer Cells in Whole Slide Images Using Deformable and Global Context Aware Faster RCNN-FPN
by
Xia Li, Zhenhao Xu, Xi Shen, Yongxia Zhou, Binggang Xiao and Tie-Qiang Li
|
|
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
by
Luigi Bennardo, Francesco Bennardo, Amerigo Giudice, Maria Passante, Stefano Dastoli, Pietro Morrone, Eugenio Provenzano, Cataldo Patruno and Steven Paul Nisticò
|
|
Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments
by
Shoichiro Ishizuki and Yoshiyuki Nakamura
|
|
Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review
by
Samiha Mohsen, Philip T. Sobash, Ghada Fahad Algwaiz, Noor Nasef, Safaa Abed Al-Zeidaneen and Nagla Abdel Karim
|
Citations | Article |
---|---|
Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques
by
François Mestdagh, Arnaud Steyaert and Patricia Lavand’homme
|
|
Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape
by
Andrew Nguyen, Alexander Nguyen, Oluwaferanmi T. Dada, Persis D. Desai, Jacob C. Ricci, Nikhil B. Godbole, Kevin Pierre and Brandon Lucke-Wold
|
|
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
by
Samantha M. Ruff, Ashish Manne, Jordan M. Cloyd, Mary Dillhoff, Aslam Ejaz and Timothy M. Pawlik
|
|
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review
by
Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton and Sandeep Sehdev
|
|
Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review
by
Tian Xiao, Sanji Ali, Danilo Giffoni M. M. Mata, Ana Elisa Lohmann and Phillip S. Blanchette
|
|
Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Review
by
Neha Desai, Mukul K. Divatia, Aniket Jadhav and Aditya Wagh
|
|
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada
by
Ravi Ramjeesingh, Prosanto Chaudhury, Vincent C. Tam, David Roberge, Howard J. Lim, Jennifer J. Knox, Jamil Asselah, Sarah Doucette, Nirlep Chhiber and Rachel Goodwin
|
|
High-LET-Radiation-Induced Persistent DNA Damage Response Signaling and Gastrointestinal Cancer Development
by
Kamendra Kumar, Santosh Kumar, Kamal Datta, Albert J. Fornace, Jr. and Shubhankar Suman
|
|
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
by
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, Leonardo Stella, Francesco Santopaolo, Maria Pallozzi, Antonio Gasbarrini and Francesca Romana Ponziani
|
|
PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues
by
Seiji Hoshi, Kei Yaginuma, Satoru Meguro, Akifumi Onagi, Kanako Matsuoka, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Soichiro Ogawa, Motohide Uemura and Yoshiyuki Kojima
|
Citations | Article |
---|---|
Sexual Outcomes after Conservative Management for Patients with Localized Penile Cancer
by
Simone Cilio, Antonio Tufano, Gabriele Pezone, Pierluigi Alvino, Gianluca Spena, Savio Domenico Pandolfo, Paola Del Prete, Claudio Amato, Rocco Damiano, Andrea Salonia, Riccardo Autorino, Alessandro Izzo, Francesco Passaro and Sisto Perdonà
|
|
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
by
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Fabio Piscaglia, Alessandro Granito and Francesco Tovoli
|
|
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
by
Sandeep R. Sehdev, Nigel S. B. Rawson, Olexiy I. Aseyev, Catriona J. Buick, Marcus O. Butler, Scott Edwards, Sharlene Gill, Joanna M. Gotfrit, Cyrus C. Hsia, Rosalyn A. Juergens, Mita Manna, Joy S. McCarthy, Som D. Mukherjee, Stephanie L. Snow, Silvana Spadafora, David J. Stewart, Jason R. Wentzell, Ralph P. W. Wong and Pawel G. Zalewski
|
|
Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma
by
Jingyi Wang and Bo Gao
|
|
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence
by
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang and Qiang Wei
|
|
Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations
by
Miklos Acs, Pompiliu Piso and Gabriel Glockzin
|
|
Relationship between Medication-Related Osteonecrosis of the Jaw and CDK4/6 Inhibitors in Breast Cancer
by
Loreto Domínguez Senín, David Morales Pancorbo, María Yeray Rodríguez Garcés, María Dolores Santos-Rubio and Juan Bayo Calero
|
|
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)
by
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo Calvo and Jesús Martín
|
|
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
by
Shamim Mortuza, Benjamin Chin-Yee, Tyler E. James, Ian H. Chin-Yee, Benjamin D. Hedley, Jenny M. Ho, Lalit Saini, Alejandro Lazo-Langner, Laila Schenkel, Pratibha Bhai, Bekim Sadikovic, Jonathan Keow, Nikhil Sangle and Cyrus C. Hsia
|
Citations | Article |
---|---|
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
by
K. Esfahani, L. Roudaia, N. Buhlaiga, S.V. Del Rincon, N. Papneja and W.H. Miller
|
|
Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy
by
Thierry Alcindor and N. Beauger
|
|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the Literature
by
N. Salvo, E. Barnes, J. van Draanen, E. Stacey, G. Mitera, D. Breen, A. Giotis, G. Czarnota, J. Pang and C. De Angelis
|
|
Nonsurgical Treatment of Recurrent Glioblastoma
by
O. Gallego
|
|
Microrna Let-7: An Emerging Next-Generation Cancer Therapeutic
by
D. Barh, R. Malhotra, B. Ravi and P. Sindhurani
|
|
Advances in the Systemic Treatment of Triple-Negative Breast Cancer
by
J.M. Lebert, R. Lester, E. Powell, M. Seal and J. McCarthy
|
|
Mindfulness-Based Stress Reduction for Breast Cancer—A Systematic Review and Meta-Analysis
by
H. Cramer, R. Lauche, A. Paul and G. Dobos
|
|
A Review of the Reliability and Validity of the Edmonton Symptom Assessment System
by
L. A. Richardson and G. W. Jones
|
|
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
by
M. Fung-Kee-Fung, T. Oliver, L. Elit, A. Oza, H. W. Hirte, P. Bryson and on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
|
Views | Article |
---|---|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
by
Hamid Mithoowani and Michela Febbraro
|
|
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges
by
Alessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, Angela Dalia Ricci and Gennaro Gadaleta-Caldarola
|
|
Current Overview of Treatment for Metastatic Bone Disease
by
Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
|
|
Immunotherapy in Gastric Cancer
by
Anica Högner and Markus Moehler
|
|
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI
by
Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić and Vladimir Dugalić
|
|
The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
by
Anna N. Wilkinson, Jean-Michel Billette, Larry F. Ellison, Michael A. Killip, Nayaar Islam and Jean M. Seely
|
|
‘Targeting’ Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer—An Updated Review
by
Saurav Verma, Daniel Breadner and Jacques Raphael
|
|
Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus
by
Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu and Agnes Y. Y. Lee
|
Views | Article |
---|---|
The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
by
Anna N. Wilkinson, Jean-Michel Billette, Larry F. Ellison, Michael A. Killip, Nayaar Islam and Jean M. Seely
|
|
‘Targeting’ Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer—An Updated Review
by
Saurav Verma, Daniel Breadner and Jacques Raphael
|
|
Applying Deep Learning for Breast Cancer Detection in Radiology
by
Ella Mahoro and Moulay A. Akhloufi
|
|
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
by
Karla Willows, Amanda Selk, Marie-Hélène Auclair, Brent Jim, Naana Jumah, Jill Nation, Lily Proctor, Melissa Iazzi and James Bentley
|
|
Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer
by
Paraskevi Detopoulou, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos and Andrea Paola Rojas Gil
|
|
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review
by
Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton and Sandeep Sehdev
|
|
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction
by
Ali A. Rabaan, Hajir AlSaihati, Rehab Bukhamsin, Muhammed A. Bakhrebah, Majed S. Nassar, Abdulmonem A. Alsaleh, Yousef N. Alhashem, Ammar Y. Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A. Alsubki, Hejji E. Alahmed, Saleh Al-Abdulhadi, Fatemah A. Alhashem, Ahlam A. Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H. Abdulal, Ali H. Al-Ahmed, Mohd. Imran and Ranjan K. Mohapatraadd
Show full author list
remove
Hide full author list
|
|
Classification of Brain Tumor from Magnetic Resonance Imaging Using Vision Transformers Ensembling
by
Sudhakar Tummala, Seifedine Kadry, Syed Ahmad Chan Bukhari and Hafiz Tayyab Rauf
|
|
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
by
Silvia Bisello, Savino Cilla, Anna Benini, Raffaele Cardano, Nam P. Nguyen, Francesco Deodato, Gabriella Macchia, Milly Buwenge, Silvia Cammelli, Tigeneh Wondemagegnehu, A. F. M. Kamal Uddin, Stefania Rizzo, Alberto Bazzocchi, Lidia Strigari and Alessio G. Morganti
|
|
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
by
Ryan J. Stubbins, Annabel Francis, Florian Kuchenbauer and David Sanford
|
Views | Article |
---|---|
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
by
Karla Willows, Amanda Selk, Marie-Hélène Auclair, Brent Jim, Naana Jumah, Jill Nation, Lily Proctor, Melissa Iazzi and James Bentley
|
|
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review
by
Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton and Sandeep Sehdev
|
|
Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques
by
François Mestdagh, Arnaud Steyaert and Patricia Lavand’homme
|
|
Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape
by
Andrew Nguyen, Alexander Nguyen, Oluwaferanmi T. Dada, Persis D. Desai, Jacob C. Ricci, Nikhil B. Godbole, Kevin Pierre and Brandon Lucke-Wold
|
|
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
by
Tiffany Zigras, Marie-Hélène Mayrand, Celine Bouchard, Shannon Salvador, Lua Eiriksson, Chelsea Almadin, Sarah Kean, Erin Dean, Unjali Malhotra, Nicole Todd, Daniel Fontaine and James Bentley
|
|
Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review
by
Tian Xiao, Sanji Ali, Danilo Giffoni M. M. Mata, Ana Elisa Lohmann and Phillip S. Blanchette
|
|
Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials
by
Jayne Lim, Michael Auerbach, Beth MacLean, Annas Al-Sharea and Toby Richards
|
|
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada
by
Ravi Ramjeesingh, Prosanto Chaudhury, Vincent C. Tam, David Roberge, Howard J. Lim, Jennifer J. Knox, Jamil Asselah, Sarah Doucette, Nirlep Chhiber and Rachel Goodwin
|
|
Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing
by
Anna N. Wilkinson, Jean M. Seely, Moira Rushton, Phillip Williams, Erin Cordeiro, Alexandra Allard-Coutu, Nicole J. Look Hong, Nikitha Moideen, Jessica Robinson, Julie Renaud, James G. Mainprize and Martin J. Yaffe
|
|
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
by
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, Leonardo Stella, Francesco Santopaolo, Maria Pallozzi, Antonio Gasbarrini and Francesca Romana Ponziani
|
Views | Article |
---|---|
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
by
Leonard J. Ash, Ottavia Busia-Bourdain, Daniel Okpattah, Avrosina Kamel, Ariel Liberchuk and Andrew L. Wolfe
|
|
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process
by
James Tankel, Jonathan Spicer, Quincy Chu, Pierre Olivier Fiset, Biniam Kidane, Natasha B. Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara Melosky, Stephanie Snow, Houda Bahig and Normand Blais
|
|
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by
Sarah Lidagoster, Reuben Ben-David, Benjamin De Leon and John P. Sfakianos
|
|
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox
by
Sara Moufarrij and Roisin E. O’Cearbhaill
|
|
Fertility Preservation in Cervical Cancer—Treatment Strategies and Indications
by
Lina Salman and Allan Covens
|
|
Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma
by
Jingyi Wang and Bo Gao
|
|
Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor
by
Lucio N. Gordan, David Ray, Stephen C. Ijioma, George Dranitsaris, Amanda Warner, Trevor Heritage, Matthew Fink, David Wenk, Paul Chadwick, Natasha Khrystolubova and Shachar Peles
|
|
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline
by
Ezekiel Weis, Brae Surgeoner, Thomas G. Salopek, Tina Cheng, Martin Hyrcza, Xanthoula Kostaras, Matthew Larocque, Greg McKinnon, John McWhae, Geetha Menon, Jose Monzon, Albert D. Murtha, John Walker and Claire Temple-Oberle
|
|
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
by
Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz and Anna M. Czarnecka
|
|
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by
Madison L. Conces and Amit Mahipal
|
Views | Article |
---|---|
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
by
K. Esfahani, L. Roudaia, N. Buhlaiga, S.V. Del Rincon, N. Papneja and W.H. Miller
|
|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
by
Hamid Mithoowani and Michela Febbraro
|
|
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
by
Athanasia Mitsala, Christos Tsalikidis, Michail Pitiakoudis, Constantinos Simopoulos and Alexandra K. Tsaroucha
|
|
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges
by
Alessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, Angela Dalia Ricci and Gennaro Gadaleta-Caldarola
|
|
Current Overview of Treatment for Metastatic Bone Disease
by
Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
|
|
Synovial Sarcoma: A Clinical Review
by
Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson and Michelle Ghert
|
|
Screening for Breast Cancer in 2018—What Should We be Doing Today?
by
J.M. Seely and T. Alhassan
|
|
Immunotherapy in Gastric Cancer
by
Anica Högner and Markus Moehler
|
Downloads | Article |
---|---|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
by
Hamid Mithoowani and Michela Febbraro
|
|
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
by
Silvia Bisello, Savino Cilla, Anna Benini, Raffaele Cardano, Nam P. Nguyen, Francesco Deodato, Gabriella Macchia, Milly Buwenge, Silvia Cammelli, Tigeneh Wondemagegnehu, A. F. M. Kamal Uddin, Stefania Rizzo, Alberto Bazzocchi, Lidia Strigari and Alessio G. Morganti
|
|
Immunotherapy in Gastric Cancer
by
Anica Högner and Markus Moehler
|
|
Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments
by
Shoichiro Ishizuki and Yoshiyuki Nakamura
|
|
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
by
Ryan J. Stubbins, Annabel Francis, Florian Kuchenbauer and David Sanford
|
|
Current Overview of Treatment for Metastatic Bone Disease
by
Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
|
|
Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
by
Enrique Gutiérrez, Irving Sánchez, Omar Díaz, Adrián Valles, Ricardo Balderrama, Jesús Fuentes, Brenda Lara, Cipatli Olimón, Víctor Ruiz, José Rodríguez, Luis H. Bayardo, Matthew Chan, Conrad J. Villafuerte, Jerusha Padayachee and Alexander Sun
|
|
Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence
by
Ilaria Attili, Antonio Passaro, Pasquale Pisapia, Umberto Malapelle and Filippo de Marinis
|
|
Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by
Maria Antonia Gómez-Aparicio, Jeannette Valero, Begoña Caballero, Rafael García, Ovidio Hernando-Requejo, Ángel Montero, Alfonso Gómez-Iturriaga, Thomas Zilli, Piet Ost, Fernando López-Campos and Felipe Couñago
|
Downloads | Article |
---|---|
A Systematic Review of Surgical Management Strategies in the Treatment of Peritoneal Carcinomatosis of Neuroendocrine Origin
by
Megan Fallows, Ambareesh Samant, Harry Wilson and Reza Mirnezami
|
|
Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques
by
François Mestdagh, Arnaud Steyaert and Patricia Lavand’homme
|
|
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
by
Karla Willows, Amanda Selk, Marie-Hélène Auclair, Brent Jim, Naana Jumah, Jill Nation, Lily Proctor, Melissa Iazzi and James Bentley
|
|
Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape
by
Andrew Nguyen, Alexander Nguyen, Oluwaferanmi T. Dada, Persis D. Desai, Jacob C. Ricci, Nikhil B. Godbole, Kevin Pierre and Brandon Lucke-Wold
|
|
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review
by
Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton and Sandeep Sehdev
|
|
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
by
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, Leonardo Stella, Francesco Santopaolo, Maria Pallozzi, Antonio Gasbarrini and Francesca Romana Ponziani
|
|
Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review
by
Tian Xiao, Sanji Ali, Danilo Giffoni M. M. Mata, Ana Elisa Lohmann and Phillip S. Blanchette
|
|
Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles
by
Mary Anne Fenton, Paolo Tarantino and Stephanie L. Graff
|
|
Multiple Myeloma in 2023 Ways: From Trials to Real Life
by
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, Alessandro Allegra, Uroš Markovic, Cirino Botta, Fabrizio Accardi, Iolanda Donatella Vincelli, Salvatore Leotta, Federica Elia, Benedetta Esposito, Bruno Garibaldi, Gabriele Sapuppo, Alessandra Orofino, Alessandra Romano, Giuseppe A. Palumbo, Francesco Di Raimondo and Concetta Conticello
|
|
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
by
Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes and Mehmet Akce
|
Downloads | Article |
---|---|
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox
by
Sara Moufarrij and Roisin E. O’Cearbhaill
|
|
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response
by
Courtney H. Coschi and Rosalyn A. Juergens
|
|
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
by
Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz and Anna M. Czarnecka
|
|
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline
by
Ezekiel Weis, Brae Surgeoner, Thomas G. Salopek, Tina Cheng, Martin Hyrcza, Xanthoula Kostaras, Matthew Larocque, Greg McKinnon, John McWhae, Geetha Menon, Jose Monzon, Albert D. Murtha, John Walker and Claire Temple-Oberle
|
|
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process
by
James Tankel, Jonathan Spicer, Quincy Chu, Pierre Olivier Fiset, Biniam Kidane, Natasha B. Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara Melosky, Stephanie Snow, Houda Bahig and Normand Blais
|
|
Fertility Preservation in Cervical Cancer—Treatment Strategies and Indications
by
Lina Salman and Allan Covens
|
|
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by
Sarah Lidagoster, Reuben Ben-David, Benjamin De Leon and John P. Sfakianos
|
|
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma
by
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Ulrike Bacher and Thomas Pabst
|
|
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by
Madison L. Conces and Amit Mahipal
|
Downloads | Article |
---|---|
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
by
K. Esfahani, L. Roudaia, N. Buhlaiga, S.V. Del Rincon, N. Papneja and W.H. Miller
|
|
Immune Checkpoint Inhibitors in Cancer Therapy
by
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
|
|
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
by
Athanasia Mitsala, Christos Tsalikidis, Michail Pitiakoudis, Constantinos Simopoulos and Alexandra K. Tsaroucha
|
|
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
by
Hamid Mithoowani and Michela Febbraro
|
|
Screening for Breast Cancer in 2018—What Should We be Doing Today?
by
J.M. Seely and T. Alhassan
|
|
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
by
Silvia Bisello, Savino Cilla, Anna Benini, Raffaele Cardano, Nam P. Nguyen, Francesco Deodato, Gabriella Macchia, Milly Buwenge, Silvia Cammelli, Tigeneh Wondemagegnehu, A. F. M. Kamal Uddin, Stefania Rizzo, Alberto Bazzocchi, Lidia Strigari and Alessio G. Morganti
|
|
Immunotherapy in Gastric Cancer
by
Anica Högner and Markus Moehler
|
|
Synovial Sarcoma: A Clinical Review
by
Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson and Michelle Ghert
|
|
The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review
by
Nicolas Iragorri, Claire de Oliveira, Natalie Fitzgerald and Beverley Essue
|
Most Cited & Viewed Special Issues
Published: Last 36 months
Avg. Citations | Special Issue |
---|---|
19.74
|
Immune Checkpoint Inhibitors in Cancer Therapy: State of the Art and Future Perspectives
Guest Editors
, and Prashanth Prithviraj |
Number of Papers: 19
|
8.83
|
New Frontiers in Treatment for Gynecologic Cancers
Guest Editors
and |
Number of Papers: 12
|
7.81
|
Hepatobiliary Malignancies: Recent Advancements and Future Directions
Guest Editor
|
Number of Papers: 21
|
6.07
|
Breast Cancer Imaging and Therapy
Guest Editor
|
Number of Papers: 14
|
4.18
|
Published: Last 36 months
Views | Special Issue |
---|---|
75562
|
Immune Checkpoint Inhibitors in Cancer Therapy: State of the Art and Future Perspectives
Guest Editors
, and Prashanth Prithviraj |
Number of Papers: 19
|
65322
|
Hepatobiliary Malignancies: Recent Advancements and Future Directions
Guest Editor
|
Number of Papers: 21
|
56864
|
Breast Cancer Imaging and Therapy
Guest Editor
|
Number of Papers: 14
|
48341
|
New Frontiers in Treatment for Gynecologic Cancers
Guest Editors
and |
Number of Papers: 12
|
45679
|
Recent Advancements in the Surgical Treatment of Brain Tumors
Guest Editor
|
Number of Papers: 17
|
40276
|
|
39611
|
New Frontiers in the Management of Retroperitoneal Soft Tissue Sarcoma
Guest Editor
|
Number of Papers: 14
|
30905
|
Combination Therapy in Gastrointestinal Cancers
Guest Editor
|
Number of Papers: 14
|
30591
|
|
30566
|